Senior Bioinformatics Scientist

The petition was approved based on the submission of 8 peer-reviewed journal articles and 174 total citations from researchers in 33 countries. Additionally, the petitioner demonstrated professional standing by completing at least 10 peer reviews for scientific journals. These metrics satisfied the regulatory requirements for the EB-1A extraordinary ability category.

The case was approved based on 5 peer-reviewed journal articles in high-impact venues like Nature, Cell, and Science, which amassed 1,359 citations from researchers in over 50 countries. The petitioner also demonstrated significant judging experience with 13 peer reviews and an editorial board position. These metrics satisfied the criteria for original contributions of major significance, scholarly authorship, and judging the work of others.

The petition was approved based on the satisfaction of at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of the work of others, and original scientific contributions of major significance. Specific metrics included 8 peer-reviewed publications in elite journals like Nature Microbiology, 260 citations placing him in the top 1% of his field, and the completion of over 20 peer reviews for high-impact journals.

The petition was approved based on a record of 17 peer-reviewed articles and 1,210 citations, demonstrating extensive independent reliance by the research community. The petitioner also provided evidence of 13 completed manuscript reviews for respected journals. Approval was further supported by original contributions in structure-guided HIV vaccine design and nucleic acid-based strategies for SARS-CoV-2.